MedPath

Evaluation of Changes in Bowel Movement Frequency Following the Consumption of PHGG in Adults with Constipation

Not Applicable
Completed
Conditions
Constipation - Functional
Registration Number
NCT04587635
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

Evaluation of Changes in Bowel Movement Frequency Following the Consumption of Partially Hydrolyzed Guar Gum (PHGG) in Adults with Constipation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
SBMBaseline to end of treatment, up to 6 weeks.

Change in mean frequency of Spontaneous Bowel Movements (SBM) as measured by the daily bowel diary from baseline to Week 6 in the treatment group compared to placebo. Frequency will be defined as the mean number of SBM for the 2-week run-in period prior to V0 and the final 2-week period of the intervention period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Atlantia Food Clinical Trial

🇮🇪

Cork, Ireland

Atlantia Food Clinical Trial
🇮🇪Cork, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.